# Venous Sinus Stenting for Challenging Cases of Idiopathic Intracranial Hypertension: A Case Series From a Tertiary Care Center in Riyadh, Saudi Arabia

**Authors:** Bashaier G AlQahtani, Turki Bin Saqyan, Maher Sahnoun

PMC · DOI: 10.7759/cureus.83534 · Cureus · 2025-05-05

## TL;DR

This case series explores the effectiveness of venous sinus stenting in treating patients with refractory idiopathic intracranial hypertension.

## Contribution

The study presents real-world outcomes of VSS in a specific patient population in Saudi Arabia.

## Key findings

- All patients showed significant improvements in intracranial pressure and visual symptoms after VSS.
- No procedural complications occurred, though one patient had transient symptom worsening.
- The study supports VSS as a potential treatment for refractory IIH, but larger studies are needed.

## Abstract

Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure that causes headaches and visual disturbances. While medical management is the primary treatment, some patients remain refractory. Venous sinus stenting (VSS) has emerged as a potential alternative. This case series discusses the outcomes of VSS in patients with refractory IIH.

Patients with IIH who underwent VSS at a tertiary hospital in Riyadh were reviewed. The data collected included demographics, clinical presentation, diagnostic imaging findings, intraprocedural pressure measurements, and clinical and radiological outcomes before and after stenting. Verbal consent was obtained from all patients for participation in this case series.

All patients demonstrated transverse sinus stenosis and had persistent symptoms despite medical therapy. Following VSS, all patients experienced significant improvements in intracranial pressure gradients, papilledema grades, visual symptoms, and the frequency and intensity of headaches. No procedural complications occurred, although one patient experienced transient worsening of symptoms after the procedure.

This case series suggests that VSS may be an effective treatment for carefully selected patients with refractory IIH and can lead to improvements in clinical and radiological outcomes. However, larger, prospective, controlled studies with longer follow-ups are needed to confirm these findings and establish the long-term efficacy and safety of VSS.

## Linked entities

- **Diseases:** idiopathic intracranial hypertension (MONDO:0009468), papilledema (MONDO:0006879)

## Full-text entities

- **Diseases:** transverse sinus stenosis (MESH:D020227), visual disturbances (MESH:D014786), IIH (MESH:D011559), papilledema (MESH:D010211), headaches (MESH:D006261)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12136561/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12136561/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12136561/full.md

---
Source: https://tomesphere.com/paper/PMC12136561